- Acquired a majority stake in Trace Analytics, Inc., a leading testing and analytics company
- Estimates of the Global cannabis testing market is projected to grow 13.2% year-over-year through 2026
- Â Applied BioSciences continues to be at the forefront of the evolving consumer market, using organically grown plants, without pesticides or herbicides as our main ingredient
(January 9, 2018) Los Angeles, CA – Applied
Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company
focused on the medical, bioceutical and pet health industries, announced that
it has acquired a majority stake in Trace Analytics, Inc., a leading testing
and analytics company. The team has over 65 years of experience in the testing
and analytics space and a full-time staff of nine employees including, two
Ph.D. analytical chemists and five other scientists.
A recent report from Coherent Market Insights1 estimates that the
global cannabis testing market is projected to grow 13.2% year-over-year
through 2026, when it is expected to surpass $1.5 billion USD.
Although the health benefits of Cannabis and CBD are becoming well
known, one of the challenges is the safety and testing of these products which
are ingested, vaped and applied topically.
Many products in the market are cheaply-made, with multiple toxins,
chemicals and synthetics. Some of the
products include high levels of THC, harmful substances, illegally processed
synthetic cannabinoids, and even some that have no CBD at all. Applied Biosciences
intends to position Trace as the leading provider of testing solutions for both
compliance requirements and consumer safety.
“Applied BioSciences continues
to be at the forefront of the evolving consumer market, using organically grown
plants, without pesticides or herbicides as our main ingredient. As the company, continues to expand our
product lines it is important to know that our products have been thoroughly
tested by trusted labs in the industry for chemicals, pesticides and any
harmful materials. All our products are
tested to ensure high-caliber and quality as well as overall safety. We will now be able to test our products in
an expedited fashion as well as from third-party labs and continue to provide the
highest standard of testing results and safety protocols on all our products.â€
commented Chris Bridges, President of Applied BioSciences Corp.
“Applied
BioSciences will allow our company and team to expand. We are excited to embark
on this new partnership. Both
organizations have a focus on quality and providing the end user the safest
possible products. The leadership teams
of both companies have decided to expand the testing offerings to include
advanced pesticide testing by purchasing a gas chromatography tandem mass
spectrometer (GC/MS/MS) to complement the liquid chromatography tandem mass
spectrometer (LC/MS/MS), as well as purchasing an ion coupled plasma mass
spectrometer (ICP/MS) for heavy metals testing. These new platforms, once
certified, will allow Trace Analytics to certify Washington State’s medical
grade cannabis as well as offering advanced analytical testing to the CBD
producers / processors from around the world.â€
commented Jason Zitzer, COO of Trace Analytics Inc.
Applied
BioSciences products use base ingredients that are USDA Organic and non-GMO.
Offering Vegan, sugar-free, 99% Pure CBD Isolate infused. The products are
formulated with CBD extracted from pesticide-free, organically grown,
domestically produced, High-CBD Industrial Hemp. Lab-tested and guaranteed
Pesticide and Chemical-free. Our
proprietary blends also contain USDA certified organic botanicals, herbals and
essential oils to provide synergy with other healing elements found in nature.
1 Coherent Market Insights – https://www.coherentmarketinsights.com/market-insight/cannabis-testing-market-170
About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas
of the medical, bioceutical and pet health industry. As a leading company in
the CBD and Pet health space, the company is currently shipping to the majority
of US states as well as to 5 International countries. The company is focused on select investment,
consumer brands, and partnership opportunities in the recreational, health and
wellness, nutraceutical, and media industries.
The company has several strategic partnerships and
investments currently in place and is actively pursuing additional partnerships
and strategic growth opportunities.
About Trace
Analytics Inc.
Trace Analytics
Inc. is a leading cannabis science and technology company with significant
footprints in lab testing, research and development and licensing. Trace
Analytics was started by a group of scientists who specialized in analytical
chemistry, genetics and molecular biology.
The focus of the team is to ensure compliance with public safety
standards and end user safety. Trace Analytics is in the process of expanding
throughout the United States, and globally. With the goal of helping the rest
of the world adopt “best practices” in cannabis and hemp testing, the
company also provides expert consulting services to legislators and regulators
in many countries, states and municipalities around the world. For more
information, please visit: http://traceanalytics.com
Contact
Email: [email protected] or [email protected]
To be added to
the Applied BioSciences email distribution list, please email [email protected]
with APPB in the subject line.
Official Website: www.appliedbiocorp.com / www.traceanalytics.com
Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com
Follow us:
Facebook
@remedicbd & @HerbalPetMeds
Instagram
@remedishop & @herbal_pet
Twitter
@remedishop & @herbal_pet